Product image
Product image
InVivoMAb anti-mouse CLEC9A (CD370)
BE0305
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse CLEC9A (CD370)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID7H11
- Concentration4-11 mg/ml
- HostRat
- IsotypeIgG1
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Snyder AG et al., 2019 Jun 21, Sci ImmunolRead more
- Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas. Picco G et al., 2014 Jul, Eur J ImmunolRead more
- Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A. Joffre OP et al., 2010 May, Eur J ImmunolRead more
- Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. Sancho D et al., 2008 Jun, J Clin InvestRead more
